Evidence map›Paper›PMID 31425540›Full record

ArticlePLoS neglected tropical diseases2019

Using detergent-enhanced LAMP for African trypanosome detection in human cerebrospinal fluid and implications for disease staging.

Dennis J Grab, Olga V Nikolskaia, Bertrand Courtioux, Oriel M M Thekisoe, Stefan Magez, Maxim Bogorad, J Stephen Dumler, Sylvie Bisser

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Sleeping Sickness at the Crossroads.Tropical medicine and infectious disease · 2020
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 6 countries.

Dennis J GrabDepartment of Pathology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America.ORCID 0000-0001-9558-6427
Olga V NikolskaiaDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Bertrand CourtiouxInstitute of Neuroepidemiology and Tropical Neurology, School of Medicine, CNRS FR 3503 GEIST, University of Limoges, INSERM UMR1094 Tropical Neuroepidemiology, Limoges, France.
Oriel M M ThekisoeUnit for Environmental Sciences and Management, North-West University, Potchefstroom, South Africa.
Stefan MagezLaboratory for Biomedical Research, Ghent University Global Campus, Incheon, South Korea.
Maxim BogoradDepartment of Pathology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America.
J Stephen DumlerDepartment of Pathology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America.ORCID 0000-0002-8476-1311
Sylvie BisserInstitute of Neuroepidemiology and Tropical Neurology, School of Medicine, CNRS FR 3503 GEIST, University of Limoges, INSERM UMR1094 Tropical Neuroepidemiology, Limoges, France.
Centre National de la Recherche Scientifique · FRJohns Hopkins University · USUniformed Services University of the Health Sciences · USNorth-West University · ZAVrije Universiteit Brussel · BE

Funding

Diagnosis of gambiense HATR01AI082695 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GRAB, DENNIS JOHN · 2009 to 2012
$1.4M
NIAID NIH HHS R01 AI082695
6 · The paper itself

Abstract

objectiveWhere human African trypanosomiasis (HAT) patients are seen, failure to microscopically diagnose infections by Trypanosoma brucei gambiense in blood smears and/or cerebrospinal fluid (CSF) in the critical early stages of the disease is the single most important factor in treatment failure, a result of delayed treatment onset or its absence. We hypothesized that the enhanced sensitivity of detergent-enhanced loop-mediated isothermal amplification (LAMP) will allow for point of care (POC) detection of African trypanosomes in the CSF of HAT patients where the probability for detecting a single parasite or parasite DNA molecule in 1 μL of CSF sample is negligible by current methods. METHODOLOGY: We used LAMP targeting the multicopy pan-T. brucei repetitive insertion mobile element (RIME LAMP) and the Trypanosoma brucei gambiense 5.8S rRNA-internal transcribed spacer 2 gene (TBG1 LAMP). We tested 1 μL out of 20 μL sham or Triton X-100 treated CSFs from 73 stage-1 and 77 stage-2 HAT patients from the Central African Republic and 100 CSF negative controls.

resultsUnder sham conditions, parasite DNA was detected by RIME and TBG1 LAMP in 1.4% of the stage-1 and stage-2 gambiense HAT CSF samples tested. After sample incubation with detergent, the number of LAMP parasite positive stage-2 CSF's increased to 26%, a value which included the 2 of the 4 CSF samples where trypanosomes were identified microscopically. Unexpected was the 41% increase in parasite positive stage-1 CSF's detected by LAMP. Cohen's kappa coefficients for RIME versus TBG1 LAMP of 0.92 (95%CI: 0.82-1.00) for stage-1 and 0.90 (95%CI: 0.80-1.00) for stage-2 reflected a high level of agreement between the data sets indicating that the results were not due to amplicon contamination, data confirmed in χ2 tests (p<0.001) and Fisher's exact probability test (p = 4.7e-13).

conclusionThis study detected genomic trypanosome DNA in the CSF independent of the HAT stage and may be consistent with early CNS entry and other scenarios that identify critical knowledge gaps for future studies. Detergent-enhanced LAMP could be applicable for non-invasive African trypanosome detection in human skin and saliva or as an epidemiologic tool for the determination of human (or animal) African trypanosome prevalence in areas where chronically low parasitemias are present.

Indexed as

Severity of Illness IndexAdolescentAdultAgedAged, 80 and overCentral African RepublicCerebrospinal FluidChildChild, PreschoolDetergentsDNA, ProtozoanDNA, RibosomalDNA, Ribosomal SpacerFemaleHumansInfantDetergentsDNA, ProtozoanDNA, RibosomalDNA, Ribosomal SpacerRNA, Ribosomal, 5.8S

Identifiers

PMID31425540
PMCPMC6715242
OpenAlexW2969465229

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.